-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Centessa Pharmaceuticals plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2020 to Q1 2025.
- Centessa Pharmaceuticals plc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$57.2M, a 53.5% decline year-over-year.
- Centessa Pharmaceuticals plc annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$142M, a 11.4% increase from 2023.
- Centessa Pharmaceuticals plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$160M, a 20% increase from 2022.
- Centessa Pharmaceuticals plc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$201M, a 48.4% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)